We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitlePhase I study of chidamide (CS055/HBI-8000), a new histone deacetylase inhibitor, in patients with advanced solid tumors and lymphomas.AuthorsDong, Mei; Ning, Zhi-Qiang; Xing, Pu-Yuan; Xu, Jia-Lian; Cao, Hai-Xiang; Dou, Gui-Fang; Meng, Zhi-Yun; Shi, Yuan-Kai; Lu, Xian-Ping; Feng, Feng-YiAbstractChidamide (CS055/HBI-8000) is a new benzamide class of histone deacetylase inhibitor with marked anti-tumor activity. This study reports the phase I results.PublicationCancer chemotherapy and pharmacology, 2012, Vol 69, Issue 6, p1413ISSN1432-0843Publication typeJournal ArticleDOI10.1007/s00280-012-1847-5